References
- Feinberg WM, Blackshear JL, Laupacis A, et al: Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995;155(5):469–473
- Kalman JM, Tonkin AM: Atrial fibrillation epidemiology and the risk and prevention of stroke. Pacing Clin Electrophysiol 1992;15(9):1332–1346
- Krahn AD, Manfreda J, Tate RB, et al: The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98(5):476–484
- Diker E, Aydogdu S, Ozdemir M, et al: Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 1996;77(1):96–98
- Forfar JC, Miller HC, Toft AD: Occult thyrotoxicosis: a correctable cause of ‘idiopathic’ atrial fibrillation. Am J Cardiol 1997;44(1):9–12
- Hiss RG, Lamb LE: Electrocardiographic findings in 122,043 individuals. Circulation 1962;25:947–961
- Paritano JA, Oriel RJ: Prevalence and nature of cardiac arrhythmias in apparently normal well-trained runners. Am Heart J 1982; 104(4 pt 2):762–768
- Coelho A, Palileo E, Ashley W, et al: Tachyarrhythmias in young athletes. J Am Coll Cardiol 1986; 7(1):237–243
- Maki T, Toivonen L, Koskinen P, et al: Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol 1998;82(3):317–322
- Peters KG, Kienzle MG: Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 1988;85(2):242–244
- Karjalainen J, Kujala UM, Kaprio J, et al: Lone atrial fibrillation in vigorously exercising middle-aged men: case-control study. BMJ 1998;316(7147): 1784–1785
- Wigle ED, Rakowski H, Kimball BP, et al: Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92(7):1680–1692
- Timmermans C, Smeets JL, Rodriguez LM, et al: Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol 1995;76(7):492–494
- MacMahon JR: Atrial fibrillation and sympathomimetics, letter. J Pediatr 1974;84(4):613
- Sporano M Grasso L, Esposito M, et al: Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet Hum Toxicol 1998; 40(3):141–143
- Kinlay S, Leitch JW, Neil A, et al: Cardiac event recorders yield more diagnoses and are moie costeffective than 48-hour Holter monitoring in patients with palpitations: a controlled clinical trial. Ann Intern Med 1996;124(1 pt l):16–20
- Falk RH, Leavitt JI: Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med 1991; 4(7):573–575
- Catlin DH, Murray TH: Performance-enhancing drugs, fair competition, and Olympic sports. JAMA 1996;276(3):231–237
- Falk RH: Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;7(2): 141–150
- Brodsky MA, Orlov MV Capparelli EV et al: Magnesium therapy in new-onset atrial fibrillation. Am J Cardiol 1994;73(16):1227–1229
- Rawles JM, Metcalfe MJ, Jennings K: Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin. Br Heart J 1990;63(4):225–227
- Reiffel JA: Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision. Am J Cardiol 1998;82(8A):72N–81N
- Ricard P Levy S, Trigano J, et al: Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997;79(6):815–816
- Laupacis A, Albers G, Dalen J, et al: Antithrombotic therapy in atrial fibrillation. Chest 1995;108(4 suppi):352S–359S
- Kopecky SL, Gersh BJ, McGoon MD, et al: The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987; 317(11):669–674
- Brignole N, Menozzi C, Gianfranchi L, et al: Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998;98(10):953–960
- Cox JL, Schuessler RB. Lappas DG, et al: An 8½ -year clinical experience with surgery for atrial fibrillation. Ann Surg 1996;224(3):267–273
- Zipes DR Garson A Jr: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities: Task Force 6: arrhythmias. J Am Coll Cardiol 1994;24(4):892–899